“These cancer cells grow, grow, grow, outgrow their blood supply, literally break off, but the blood vessels are still there, shooting blood into the colon, for lack of a better term,” he explained.

Along the way, food is broken down, sorted, and reprocessed before being circulated around the body to nourish and replace cells and supply energy ... absorbed into the blood by the small ...

Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...

Bowel resection, also called partial colectomy, removes a diseased or damaged part of the colon or rectum. Bowel resection can be done for many diseases that affect the colon, such as colorectal ...

It is an industry that was supposed to be cleaned up, after the turn-of-the-millennium­ notoriety surrounding so-called blood or conflict ... In an age of supply-chain transparency, when ...

A fecal impaction is a large, hard mass of stool that gets stuck so badly in your colon or rectum that you can’t push it out. You may also be unable to sense or respond when stool is in your rectum.

U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths. For the first time, TV cameras were ...

The U.S. Food and Drug Administration recently approved Guardant Health’s blood test, Shield, to screen for colon cancer. “The blood test can detect colorectal cancer about 80% of the time ...

Over the weekend, during the lead-up to Exact Sciences announcing data from a blood-based colon cancer test, Guardant Health co-CEO AmirAli Talasaz challenged Exact’s CEO, Kevin Conroy ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced that a blood-based test it’s developing showed promise in accurately detecting the disease.